Inflammatory mediators in exhaled breath condensate of healthy donors and exacerbated COPD patients

Cytokine

Volumn 58, Issue 3, 2012, Pages 361-367

  Tateosian, Nancy L ^a   Costa, María J ^a   Guerrieri, Diego ^a   Barro, Analía ^b   Mazzei, Juan A ^b   Eduardo Chuluyan, H ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b HOSPITAL DE CLÍNICAS JOSÉ DE SAN MARTÍN   (Argentina)

Author keywords

COPD; Exhaled breath condensate; IFN ; MPO; SLPI

Indexed keywords

ALBUMIN; GAMMA INTERFERON; MYELOPEROXIDASE; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; COLORIMETRY; CONTROLLED STUDY; DISEASE EXACERBATION; EXHALED BREATH CONDENSATE; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; HUMAN TISSUE; IMMUNOASSAY; LIMIT OF DETECTION; MALE; NON INVASIVE PROCEDURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIVITY ANALYSIS; SPIROMETRY; TISSUE LEVEL; VITAL CAPACITY;

ADULT; BREATH TESTS; CASE-CONTROL STUDIES; FEMALE; HUMANS; INFLAMMATION MEDIATORS; INTERFERON-GAMMA; MALE; MIDDLE AGED; PEROXIDASE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SECRETORY LEUKOCYTE PEPTIDASE INHIBITOR; SPIROMETRY;

EID: 84860318353     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2012.03.006     Document Type: Article

References (48)

1. Montuschi P. Analysis of exhaled breath condensate in respiratory medicine: methodological aspects and potential clinical applications. Ther Adv Respir Dis 2007, 1(1):5-23.
2. Horvath I., Hunt J., Barnes P.J., Alving K., Antczak A., Baraldi E., et al. Exhaled breath condensate: methodological recommendations and unresolved questions. Eur Respir J 2005, 26(3):523-548.
3. Effros R.M., Dunning M.B., Biller J., Shaker R. The promise and perils of exhaled breath condensates. Am J Physiol Lung Cell Mol Physiol 2004, 287(6):L1073-L1080.
4. Rahman I., Biswas S.K. Non-invasive biomarkers of oxidative stress: reproducibility and methodological issues. Redox Rep 2004, 9(3):125-143.
5. Rosias P.P., Dompeling E., Hendriks H.J., Heijnens J.W., Donckerwolcke R.A., Jobsis Q. Exhaled breath condensate in children: pearls and pitfalls. Pediatr Allergy Immunol 2004, 15(1):4-19.
6. Zacharasiewicz A., Wilson N., Lex C., Li A., Kemp M., Donovan J., et al. Repeatability of sodium and chloride in exhaled breath condensates. Pediatr Pulmonol 2004, 37(3):273-275.
7. Garey K.W., Neuhauser M.M., Robbins R.A., Danziger L.H., Rubinstein I. Markers of inflammation in exhaled breath condensate of young healthy smokers. Chest 2004, 125(1):22-26.
8. Jackson A.S., Sandrini A., Campbell C., Chow S., Thomas P.S., Yates D.H. Comparison of biomarkers in exhaled breath condensate and bronchoalveolar lavage. Am J Respir Crit Care Med 2007, 175(3):222-227.
9. Koczulla A.R., Noeske S., Herr C., Jorres R.A., Rommelt H., Vogelmeier C., et al. Acute and chronic effects of smoking on inflammation markers in exhaled breath condensate in current smokers. Respiration 2010, 79(1):61-67.
10. Van Hoydonck P.G., Wuyts W.A., Vanaudenaerde B.M., Schouten E.G., Dupont L.J., Temme E.H. Quantitative analysis of 8-isoprostane and hydrogen peroxide in exhaled breath condensate. Eur Respir J 2004, 23(2):189-192.
11. Vass G., Huszar E., Barat E., Horvath I. Exhaled breath condensate and its analysis - a new method in pulmonology. Orv Hetil 2003, 144(51):2517-2524.
12. Shahid S.K., Kharitonov S.A., Wilson N.M., Bush A., Barnes P.J. Increased interleukin-4 and decreased interferon-gamma in exhaled breath condensate of children with asthma. Am J Respir Crit Care Med 2002, 165(9):1290-1293.
13. Sack U., Scheibe R., Wotzel M., Hammerschmidt S., Kuhn H., Emmrich F., et al. Multiplex analysis of cytokines in exhaled breath condensate. Cytometry A 2006, 69(3):169-172.
14. Bucchioni E., Kharitonov S.A., Allegra L., Barnes P.J. High levels of interleukin-6 in the exhaled breath condensate of patients with COPD. Respir Med 2003, 97(12):1299-1302.
15. Gessner C., Hammerschmidt S., Kuhn H., Seyfarth H.J., Sack U., Engelmann L., et al. Exhaled breath condensate acidification in acute lung injury. Respir Med 2003, 97(11):1188-1194.
16. McRae K., De Perrot M., Fischer S., Waddell T.K., Liu M., Keshavjee S. Detection of IL-10 in the exhaled breath condensate, plasma and tissue during ischemia-reperfusion injury in experimental lung transplantation. J Heart Lung Transplant 2001, 20(2):184.
17. Pant S., Walters E.H., Griffiths A., Wood-Baker R., Johns D.P., Reid D.W. Airway inflammation and anti-protease defences rapidly improve during treatment of an acute exacerbation of COPD. Respirology 2009, 14(4):495-503.
18. Roghanian A., Drost E.M., MacNee W., Howie S.E., Sallenave J.M. Inflammatory lung secretions inhibit dendritic cell maturation and function via neutrophil elastase. Am J Respir Crit Care Med 2006, 174(11):1189-1198.
19. Tremblay G.M., Sallenave J.M., Israel-Assayag E., Cormier Y., Gauldie J. Elafin/elastase-specific inhibitor in bronchoalveolar lavage of normal subjects and farmer's lung. Am J Respir Crit Care Med 1996, 154(4 Pt. 1):1092-1098.
20. Rosias P.P., Robroeks C.M., Niemarkt H.J., Kester A.D., Vernooy J.H., Suykerbuyk J., et al. Breath condenser coatings affect measurement of biomarkers in exhaled breath condensate. Eur Respir J 2006, 28(5):1036-1041.
21. Tateosian N., Kehoe Wilson C., Maffia P.C., Chuluyan H.E., Mazzei J.A. Myeloperoxidase in exhaled breath condensate reflects the status of lung parenchyma during the exacerbation of chronic obstructive pulmonary disease. Eur Resp J 2005, 26(Suppl. 49):54S.
22. Tufvesson E., Bjermer L. Methodological improvements for measuring eicosanoids and cytokines in exhaled breath condensate. Respir Med 2006, 100(1):34-38.
23. Hansson M., Olsson I., Nauseef W.M. Biosynthesis, processing, and sorting of human myeloperoxidase. Arch Biochem Biophys 2006, 445(2):214-224.
24. Winterbourn C.C., Vissers M.C., Kettle A.J. Myeloperoxidase. Curr Opin Hematol 2000, 7(1):53-58.
25. Pauwels R.A., Buist A.S., Calverley P.M., Jenkins C.R., Hurd S.S. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001, 163(5):1256-1276.
26. Rosias P.P., Robroeks C.M., Kester A., den Hartog G.J., Wodzig W.K., Rijkers G.T., et al. Biomarker reproducibility in exhaled breath condensate collected with different condensers. Eur Respir J 2008, 31(5):934-942.
27. Robroeks C.M., Jobsis Q., Damoiseaux J.G., Heijmans P.H., Rosias P.P., Hendriks H.J., et al. Cytokines in exhaled breath condensate of children with asthma and cystic fibrosis. Ann Allergy Asthma Immunol 2006, 96(2):349-355.
28. Bland J.M., Altman D.G. Measuring agreement in method comparison studies. Stats Methods Med Res 1999, 8(2):135-160.
29. Effros R.M., Su J., Casaburi R., Shaker R., Biller J., Dunning M. Utility of exhaled breath condensates in chronic obstructive pulmonary disease: a critical review. Curr Opin Pulm Med 2005, 11(2):135-139.
30. Borrill Z.L., Roy K., Singh D. Exhaled breath condensate biomarkers in COPD. Eur Respir J 2008, 32(2):472-486.
31. Effros R.M., Peterson B., Casaburi R., Su J., Dunning M., Torday J., et al. Epithelial lining fluid solute concentrations in chronic obstructive lung disease patients and normal subjects. J Appl Physiol 2005, 99(4):1286-1292.
32. Montuschi P., Barnes P.J. Analysis of exhaled breath condensate for monitoring airway inflammation. Trends Pharmacol Sci 2002, 23(5):232-237.
33. Effros R.M., Hoagland K.W., Bosbous M., Castillo D., Foss B., Dunning M., et al. Dilution of respiratory solutes in exhaled condensates. Am J Respir Crit Care Med 2002, 165(5):663-669.
34. Tzortzaki E.G., Lambiri I., Vlachaki E., Siafakas N.M. Biomarkers in COPD. Curr Med Chem 2007, 14(9):1037-1048.
35. Louis R., Lau L.C., Bron A.O., Roldaan A.C., Radermecker M., Djukanovic R. The relationship between airways inflammation and asthma severity. Am J Respir Crit Care Med 2000, 161(1):9-16.
36. Woolhouse I.S., Bayley D.L., Stockley R.A. Effect of sputum processing with dithiothreitol on the detection of inflammatory mediators in chronic bronchitis and bronchiectasis. Thorax 2002, 57(8):667-671.
37. Kelly M.M., Keatings V., Leigh R., Peterson C., Shute J., Venge P., et al. Analysis of fluid-phase mediators. Eur Respir J 2002, 37:24s-39s.
38. Di Stefano A., Caramori G., Ricciardolo F.L., Capelli A., Adcock I.M., Donner C.F. Cellular and molecular mechanisms in chronic obstructive pulmonary disease: an overview. Clin Exp Allergy 2004, 34(8):1156-1167.
39. Makris D., Lazarou S., Alexandrakis M., Kourelis T.V., Tzanakis N., Kyriakou D., et al. Tc2 response at the onset of COPD exacerbations. Chest 2008, 134(3):483-488.
40. Hill A.T., Campbell E.J., Bayley D.L., Hill S.L., Stockley R.A. Evidence for excessive bronchial inflammation during an acute exacerbation of chronic obstructive pulmonary disease in patients with alpha(1)-antitrypsin deficiency (PiZ). Am J Respir Crit Care Med 1999, 160(6):1968-1975.
41. Hollander C., Westin U., Wallmark A., Piitulainen E., Sveger T., Janciauskiene S.M. Plasma levels of alpha1-antichymotrypsin and secretory leukocyte proteinase inhibitor in healthy and chronic obstructive pulmonary disease (COPD) subjects with and without severe alpha1-antitrypsin deficiency. BMC Pulm Med 2007, 7:1.
42. Bayley D.L., Abusriwil H., Ahmad A., Stockley R.A. Validation of assays for inflammatory mediators in exhaled breath condensate. Eur Respir J 2008, 31(5):943-948.
43. Kasielski M., Nowak D. Long-term administration of N-acetylcysteine decreases hydrogen peroxide exhalation in subjects with chronic obstructive pulmonary disease. Respir Med 2001, 95(6):448-456.
44. Paredi P., Kharitonov S.A., Leak D., Ward S., Cramer D., Barnes P.J. Exhaled ethane, a marker of lipid peroxidation, is elevated in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000, 162(2 Pt. 1):369-373.
45. Kharitonov S.A., Yates D.H., Chung K.F., Barnes P.J. Changes in the dose of inhaled steroid affect exhaled nitric oxide levels in asthmatic patients. Eur Respir J 1996, 9(2):196-201.
46. Czebe K., Kullmann T., Csiszer E., Barat E., Horvath I., Antus B. Variability of exhaled breath condensate pH in lung transplant recipients. Respiration 2008, 75(3):322-327.
47. Davis C.S., Gagermeier J., Dilling D., Alex C., Lowery E., Kovacs E.J., et al. A review of the potential applications and controversies of non-invasive testing for biomarkers of aspiration in the lung transplant population. Clin Transplant 2010, 24(3):E54-E61.
48. Antus B., Barta I., Czebe K., Horvath I., Csiszer E. Analysis of cytokine pattern in exhaled breath condensate of lung transplant recipients with bronchiolitis obliterans syndrome. Inflamm Res 2010, 59(1):83-86.